OLMA250117P12500
- 6.26
- 0.000.00%
Olema Pharmaceuticals Newsroom
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $30
J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)
H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30
Oppenheimer Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30
Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)
TD Cowen Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
TD Cowen Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)
H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30
Olema Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target
Olema Pharmaceuticals: Promising Clinical Data and Growth Potential Warrant a Buy Rating
LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
Positive Outlook on Olema Pharmaceuticals: Strategic Collaborations and Promising Trial Results Boost Buy Rating
Citi Remains a Buy on Olema Pharmaceuticals (OLMA)
TD Cowen Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29
J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)
A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $29 to $30
Olema Pharmaceuticals Analyst Ratings